Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

Tetra Pharm Technologies Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Denmark

View original content:https://www.prnewswire.co.uk/news-releases/tetra-pharm-technologies-advances-cb1-antagonist-tpt0701-for-appetite-suppression-into-preclinical-testing-302054817.html